Unless stated otherwise, the information on this website is free of rights and may be used for private, association, scientific and commercial purposes. The FAMHP does, however, recommend stating the source and date of the information that is reused.

Where prior authorisation is required, or where specific conditions are necessary, reuse restrictions are explicitly mentioned. The reuse of multimedia content (photographs, images, sound, videos, etc.), including the content contained in downloadable documents (brochures, etc.), is always subject to prior approval.

The Federal Agency for Medicines and Health Products uses the following official social media channels:

How to request access to FAMHP board documents?

• Transparency
• Social media
• Conditions for reuse (Creative Commons-0 licence)

The FAMHP actively participates in a number of programmes and funds financed by the European Union. 

1. Ongoing projects

• The UNICOM project

BCFI

The Belgian Centre for Pharmacotherapeutic Information asbl/vzw (BCFI/CBIP) is subsidised and logistically supported by the FAMHP and issues the Commented Repertory of Medicines, the Folia Pharmacotherapeutica and the Transparency worksheets. These publications are sent for free to doctors, pharmacists and dentists.

Brochure: FAMHP customer charter

Given the diversity of our agency's areas of competence, the various technical and scientific expertise must be present, and consolidated both internally and externally. This must be done through strictly defined, transparent and secure partnerships. This explains the absolute necessity of cooperative links between competent authorities, whether national, European or even global.

The strengthening and expansion of interaction mechanisms with our partners is one of the major achievements since the creation of the FAMHP.

• Partners
• FAMHP customer charter
• Partners receiving financial support from the FAMHP
• The FAMHP a